Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

Add To Watchlist

Bullboard (TSX:TH)

View:

Comment by SPCEO1on May 24, 2024 10:47am

RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Unfortunately, the leadership team has burned through nearly all of their credibility. So, while there was good news in that press release, few are even reading it and fewer still are going to react ...more

122

Discussion

Comment by ANALIAS00on May 24, 2024 9:55am

RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Nobody seems to care !! That is weird.

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by Saurus100on May 24, 2024 8:45am

RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Usually, they are doing their best to keep the information confidential until the day of the event. Often, results are announced at that time, specially first phase.... Why, between May ...more

142

Discussion

Comment by scarlet1967on May 23, 2024 9:57pm

RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Apart from the clinical efficacy they are talking about and lower concentration of free doxetaxel one thing which they are "suggesting" and I found it interesting is the " ...more

195

Discussion

Comment by muslix1on May 23, 2024 8:02pm

RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

tk god to hit me... finally a good news for THTX

Discussion

Comment by Trogarzonon May 23, 2024 6:42pm

RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Very encouraging news... I think this is major.

Discussion

Comment by juniper88on May 23, 2024 5:43pm

RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

I won't pretend to know the science as qwerty or scarlett would know. But from a patient's point of view getting 45 weeks of stable disease at this late stage is quite something. ...more

145

Discussion

Comment by palinc2000on May 23, 2024 5:13pm

RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

QWERTY Can you comment and or add colour ?

Discussion

(0)
•••

Post by PressReleaseon May 23, 2024 5:00pm

New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlightsdurable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable tolerability sets stage for Part 3 (dose optimization) of Phase 1 trial, already underway MONTREAL...read article.

Comment by Trogarzonon May 23, 2024 9:49am

RE:RE:RE:Trogarzo® Intramuscular Method refusal by FDA

Exciting ain't it... woohoo 40 cents summer and a ongoing concern. Enjoy the weather and tahnk you for your patience, all 30 years of it.

Discussion

Comment by SPCEO1on May 22, 2024 4:12pm

RE:RE:Trogarzo® Intramuscular Method refusal by FDA

I suspect you were thinking about the F8 formulation of Egrifta as we were supposed to hear something about it being resubmitted but that has not happened yet. While such things always seem to take ...more

136

Discussion

Comment by palinc2000on May 22, 2024 3:42pm

RE:Trogarzo® Intramuscular Method refusal by FDA

April 10 2024 CC What more do you need? Finally, I want to touch on the Intramuscular Administration of the Trogarzo maintenance dose. The refusal to file letter received from the FDA in February ...more

Discussion

Comment by Trogarzonon May 22, 2024 3:03pm

RE:Trogarzo® Intramuscular Method refusal by FDA

They said that IM was not being pursued already. Never really understood the added value since IV push was just approved and much better than the original one. Trogarzo is tending sideways ...more

Discussion

Post by muslix1on May 22, 2024 2:53pm

Trogarzo® Intramuscular Method refusal by FDA

No news by Marsolais, close 3 months later... ''We will now assess our options regarding this application.” He said.. we abandon the intramuscular project or what News please

121

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:TH)